» Articles » PMID: 8806246

Category of Exposure to HIV and Age in the Progression to AIDS: Longitudinal Study of 1199 People with Known Dates of Seroconversion. HIV Italian Seroconversion Study Group

Overview
Journal BMJ
Specialty General Medicine
Date 1996 Sep 7
PMID 8806246
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To determine whether rate of development of AIDS is affected by category of exposure to HIV and whether the more rapid development found in older subjects persists for each exposure category.

Design: Longitudinal study of people with known date of seroconversion to HIV.

Setting: 16 HIV treatment centres throughout Italy.

Subjects: 1199 people infected with HIV through use of injected drugs, homosexual sex, or heterosexual sex.

Main Outcome Measures: AIDS as defined by 1987 definition of Centers for Disease Control (including and excluding neoplasms) and by 1993 European definition.

Results: 225 subjects (18.8%) progressed to AIDS (Centers for Disease Control 1987 definition) during median follow up of 5.8 years. Univariate analyses showed more rapid progression to AIDS for older subjects compared with younger subjects and for homosexual men compared with other exposure categories. The age effect was of similar size in each exposure category and in men and women. In a bivariate model with age and exposure categories simultaneously included as covariates, differences by exposure category disappeared for use of injected drugs and heterosexual sex compared with homosexual sex (relative hazards 1.02 (95% confidence interval 0.71 to 1.45) and 1.07 (0.70 to 1.64) respectively), while the age effect remained (relative hazard 1.55 (1.32 to 1.83) for 10 year increase in age). Analyses using the other definitions for AIDS did not appreciably change these results.

Conclusions: There was no evidence of differences in rate of development of AIDS by exposure category, while there was a strong tendency for more rapid development in older subjects for all three groups. This supports the view that external cofactors do not play major role in AIDS pathogenesis but that age is of fundamental importance.

Citing Articles

Prediction of extended high viremia among newly HIV-1-infected persons in sub-Saharan Africa.

Powers K, Price M, Karita E, Kamali A, Kilembe W, Allen S PLoS One. 2018; 13(4):e0192785.

PMID: 29614069 PMC: 5882095. DOI: 10.1371/journal.pone.0192785.


Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study.

Johnson L, May M, Dorrington R, Cornell M, Boulle A, Egger M PLoS Med. 2017; 14(12):e1002468.

PMID: 29232366 PMC: 5726614. DOI: 10.1371/journal.pmed.1002468.


Identifying factors associated with changes in CD4(+) count in HIV-infected adults in Saskatoon, Saskatchewan.

Hunt K, Mondal P, Konrad S, Skinner S, Gartner K, Lim H Can J Infect Dis Med Microbiol. 2015; 26(4):207-11.

PMID: 26361489 PMC: 4556182. DOI: 10.1155/2015/136568.


Predictors of virologic response in persons who start antiretroviral therapy during recent HIV infection.

Karris M, Kao Y, Patel D, Dawson M, Woods S, Vaida F AIDS. 2014; 28(6):841-9.

PMID: 24401640 PMC: 4049563. DOI: 10.1097/QAD.0000000000000149.


Cancer, immunodeficiency and antiretroviral treatment: results from the Australian HIV Observational Database (AHOD).

Petoumenos K, van Leuwen M, Vajdic C, Woolley I, Chuah J, Templeton D HIV Med. 2012; 14(2):77-84.

PMID: 22934689 PMC: 3535176. DOI: 10.1111/j.1468-1293.2012.01038.x.


References
1.
Jason J, Lui K, Ragni M, Hessol N, Darrow W . Risk of developing AIDS in HIV-infected cohorts of hemophilic and homosexual men. JAMA. 1989; 261(5):725-7. View

2.
Giesecke J, Berglund O, Berntorp E, Schulman S, Stigendal L . Incidence of symptoms and AIDS in 146 Swedish haemophiliacs and blood transfusion recipients infected with human immunodeficiency virus. BMJ. 1988; 297(6641):99-102. PMC: 1833803. DOI: 10.1136/bmj.297.6641.99. View

3.
Peterson P, Sharp B, Gekker G, Portoghese P, Sannerud K, Balfour Jr H . Morphine promotes the growth of HIV-1 in human peripheral blood mononuclear cell cocultures. AIDS. 1990; 4(9):869-73. DOI: 10.1097/00002030-199009000-00006. View

4.
Biggar R . AIDS incubation in 1891 HIV seroconverters from different exposure groups. International Registry of Seroconverters. AIDS. 1990; 4(11):1059-66. DOI: 10.1097/00002030-199011000-00002. View

5.
Mientjes G, Miedema F, van Ameijden E, van den Hoek A, Schellekens P, Roos M . Frequent injecting impairs lymphocyte reactivity in HIV-positive and HIV-negative drug users. AIDS. 1991; 5(1):35-41. DOI: 10.1097/00002030-199101000-00005. View